| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.977 | 7.324 | 5.398 | 5.238 | 4.073 | 4.148 | 4.036 | 5.042 |
| Total Income - EUR | - | - | 1.980 | 7.325 | 5.527 | 5.281 | 4.106 | 4.160 | 4.064 | 5.300 |
| Total Expenses - EUR | - | - | 361 | 2.516 | 5.334 | 6.867 | 3.851 | 390 | 4.606 | 9.165 |
| Gross Profit/Loss - EUR | - | - | 1.619 | 4.809 | 194 | -1.585 | 255 | 3.770 | -542 | -3.865 |
| Net Profit/Loss - EUR | - | - | 1.560 | 4.589 | 143 | -1.635 | 214 | 3.731 | -542 | -3.865 |
| Employees | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oancea Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 77 | 32 | 431 | 192 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 2.681 | 5.143 | 5.586 | 5.449 | 5.425 | 7.610 | 8.336 | 3.956 |
| Inventories | - | - | 0 | 0 | 102 | 312 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 387 | 387 | 1.669 | 401 | 113 | 521 |
| Cash | - | - | 2.681 | 5.143 | 5.097 | 4.750 | 3.756 | 7.209 | 8.223 | 3.435 |
| Shareholders Funds | - | - | 1.604 | 4.644 | 4.697 | 2.973 | 3.122 | 6.863 | 6.300 | 2.400 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.154 | 531 | 1.320 | 2.668 | 2.303 | 747 | 2.036 | 1.556 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7810 - 7810" | |||||||||
| CAEN Financial Year |
7810
|
|||||||||
Comments - Oancea Intermed S.r.l.